Image of a healthcare professional in ppe with a shield blocking a virus to show Industry responds to call to roll out coronavirus tests

Industry responds to call to roll out coronavirus tests

The UK’s top pharmaceutical and diagnostic companies are teaming up to rapidly develop and roll out millions of coronavirus tests in the coming months...
Graphic image of a hospital to show Private hospital merger to be approved if local concerns addressed

Private hospital merger to be approved if local concerns addressed

The CMA has found that the completed private hospital merger between Circle and BMI does not raise UK-wide competition concerns but could reduce competition...
Image of test tubes to show Cancer Research UK to cut funding

Cancer Research UK to cut funding by £44m

Cancer Research UK has announced that it has taken the difficult decision to cut funding to its existing grants and institutes by up to...
Image of COVID-19 spike proteint and ADDomer COVIDE-19 vaccine candidate to show New vaccine platform used to develop COVID-19 vaccine candidates

New vaccine platform used to develop COVID-19 vaccine candidates

UK biotech Imophoron has produced multiple COVID-19 vaccine candidates, based on its novel vaccine platform (ADDomer©), within weeks of the virus sequence being made...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...
Image f hospotal bed to show New NICE COVID-19 guidelines include severe asthma, pneumonia and symptom management

NICE COVID-19 guidelines: severe asthma, pneumonia, rheumatological disorders, symptom management

New NICE COVID-19 guidelines have been published on severe asthma, pneumonia, rheumatological disorders and symptom management in community settings. NICE has published the four new...
Image of a scientist at a lab to show Life sciences industry releases COVID-19 testing and diagnostics FAQs

Life sciences industry releases COVID-19 testing and diagnostics FAQs

The life sciences industry released a joint statement on COVID-19 testing and diagnostics along with useful COVID-19 testing and diagnostics FAQs. The FAQs have been...
Image of a scientist testing to show Life sciences COVID-19 testing and diagnostics statement

Life sciences’ COVID-19 testing and diagnostics statement

The life sciences industry has released a joint statement on COVID-19 testing and diagnostics as the Government confirms that testing capacity will increase. The statement...
Image of a target with an arrow in the middle to show Rapid COVID-19 diagnostic test to be deployed in hospitals

Rapid COVID-19 diagnostic test to be deployed in hospitals

A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
Image of a hospital corridor to show Interim analysis data for Siltuximab-Treated COVID-19 Patients from the SISCO Study

Interim analysis data for Siltuximab-Treated COVID-19 Patients study

An update on the Siltuximab clinical study brings interim analysis data for Siltuximab-Treated COVID-19. EUSA Pharma has announced the initial preliminary findings from the Papa...

Latest articles

Partnership announced to fight against counterfeit drugs

Partnership announced to fight against counterfeit drugs

Advanco and Syntegon have announced a strategic partnership, marking a significant step towards helping to eradicate the growing problem of counterfeit drugs. The counterfeit...
Image of a newspaper, cup, classes and pencil to show GSK receives CHMP positive opinion for Zejula▼(niraparib)

GSK receives CHMP positive opinion for Zejula▼(niraparib)

GSK receives CHMP positive opinion recommending approval of Zejula▼(niraparib) as first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer. GlaxoSmithKline (GSK) plc announced...
Image of a contract and pen to show WAYLIVRA ▼® (volanesorsen) for FCS to be available on the NHS in England

WAYLIVRA▼® (volanesorsen) for FCS to be available on the NHS in England

The National Institute for Health and Care Excellence (NICE) has issued a positive recommendation for WAYLIVRA▼® (volanesorsen), the first and only therapy for adults...

Popular articles

Image of a person descending a ladder over coronavirus to show New Normal, New Thinking: Life Post COVID-19

New Normal, New Thinking: Life Post COVID-19

New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Image of a target with an arrow in the middle to show Rapid COVID-19 diagnostic test to be deployed in hospitals

Rapid COVID-19 diagnostic test to be deployed in hospitals

A new rapid COVID-19 diagnostic test developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes,...
Image of a newspaper, cup, classes and pencil to show GSK receives CHMP positive opinion for Zejula▼(niraparib)

GSK receives CHMP positive opinion for Zejula▼(niraparib)

GSK receives CHMP positive opinion recommending approval of Zejula▼(niraparib) as first-line monotherapy maintenance treatment for women with platinum-responsive advanced ovarian cancer. GlaxoSmithKline (GSK) plc announced...
Image of a number of blocks and levels with different icons including magnifying glass, target, steps and graphs to show Coronavirus clinical research brought together in free information centre

Understanding the role of the MSL

Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...
Image of a scientist at their lab to show Study shows existing anti-parasitic drug kills coronavirus within 48 hours

Study shows anti-parasitic drug ivermectin kills coronavirus within 48 hours

A collaborative study led by the Monash Biomedicine Discovery Institute (BDI) with the Peter Doherty Institute of Infection and Immunity (Doherty Institute), a joint...

Subscribe

Sign up to receive your free UK subscription to Pf Magazine and our digital newsletters, for all the essential headlines, Jobs of the Week, and thought-provoking features.

Claim my free subscription